Pancreatic cancer : current therapeutics and future directions / Shubham Pant, editor.
2023
RC280.P25
Linked e-resources
Linked Resource
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
Pancreatic cancer : current therapeutics and future directions / Shubham Pant, editor.
ISBN
9783031386237 (electronic bk.)
303138623X (electronic bk.)
9783031386220
3031386221
303138623X (electronic bk.)
9783031386220
3031386221
Published
Cham : Springer, [2023]
Copyright
©2023
Language
English
Description
1 online resource (vii, 196 pages) : illustrations (some color)
Item Number
10.1007/978-3-031-38623-7 doi
Call Number
RC280.P25
Dewey Decimal Classification
616.99/437
Summary
Pancreatic cancer is a challenging and complex disease characterized by a dense fibrotic stroma and an immunosuppressive tumor microenvironment. Until recently, there were no predictive biomarkers to personalize selection of targeted or biologic therapies as a part of standard of care treatment. Moreover, the regulatory immune population of cells creates a cold, non-immunogenic tumor that is resistant to immunotherapies including checkpoint inhibitors. However, in the last few years, there has been substantial progress in our understanding of the role mutations in the pathogenesis of disease leading to increased adoption of germline and next generation sequencing to identify mutations and fusions to optimize selection of therapies and select patients for clinical trials of targeted agents. This book provides a comprehensive, global overview on therapy for pancreatic cancer, exploring approved therapies and focusing on the Next in drug development including molecularly targeted therapy and efforts at Drugging the Undruggable: the KRAS mutation. It also addresses efforts at targeting the inhospitable stroma to improve drug delivery to the tumor cells, incorporating ct DNA (liquid biopsies) in the care of patients and recent advances in immunotherapy. Pancreatic Cancer: Current Therapeutics and Future Directions will illuminate these challenges, review existing therapeutics, and highlight current and future efforts to improve outcomes in this devastating disease. Useful to physicians, fellows, medical students, residents, physician assistants, nurse practitioners, pharmaceutical companies and researchers interested in pancreatic cancer, it will first explain management of localized disease including resectability and adjuvant and neoadjuvant therapies. Targeted therapies including molecular, immunotherapy, stroma and role of ctDNA or liquid biopsies will be addressed. Finally, the book will explore the important role of pain management, diet and exercise in improving outcomes in pancreatic cancer.
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed November 21, 2023).
Added Author
Available in Other Form
Print version: 9783031386220
Linked Resources
Record Appears in
Table of Contents
Resectable Pancreatic Cancer: Neoadjuvant and Adjuvant Therapy
Borderline Resectable and Locally Advanced Pancreatic Cancer
Radiation Therapy for Pancreatic Cancer: Current and Evolving Paradigms
Therapies for Metastatic Pancreatic Cancer
Targeted Therapies for Pancreatic Cancer
Immunotherapy for Pancreatic Cancer
Liquid Biopsies for pancreatic cancer: Is it ready for prime time?
Supportive Care challenges and management in Pancreatic Cancer
Physical activity and nutrition optimization in pancreatic cancer.
Borderline Resectable and Locally Advanced Pancreatic Cancer
Radiation Therapy for Pancreatic Cancer: Current and Evolving Paradigms
Therapies for Metastatic Pancreatic Cancer
Targeted Therapies for Pancreatic Cancer
Immunotherapy for Pancreatic Cancer
Liquid Biopsies for pancreatic cancer: Is it ready for prime time?
Supportive Care challenges and management in Pancreatic Cancer
Physical activity and nutrition optimization in pancreatic cancer.